Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Check our last paper - AI-enhanced cardiac digital twins extend drug proarrhythmic risk assessment through experimental data uncertainty propagation and overdose exploration: A loperamide case study

Products
- V.HEART Trials
  Configure, run and analyse virtual clinical trials on the cloud
- V.HEART Discovery
  Select candidates with human QT prolongation
Technology
About Us
Newsroom

Request a Demo

Products
- V.HEART Trials
  Configure, run and analyse virtual clinical trials on the cloud
- V.HEART Discovery
  Select candidates with human QT prolongation
Technology
About Us
Newsroom

Request a Demo

Back

Media Coverage

•

December 18, 2024

ELEM Biotech, the startup that wants to bring the future of medicine closer

ELEM Biotech, the startup that wants to bring the future of medicine closer

Table of contents

Virtual humans and digital twins for testing drugs and devices

Products
- V.HEART Trials
- V.HEART Discovery
Technology
About Us
Newsroom
Contact Us

We’re located at

Spain

ELEM Biotech SL
NIF B-67260281
Pier07 - Via Laietana, 26
4th Floor, Office B
08003 Barcelona, Spain
contact@elem.bio

United Kingdom

ELEM Biotech SL
Engine Shed - SetSquared
Station Approach - Bristol Temple Meads
Bristol BS1 6QH - United Kingdom
(+44) 117 903 1100
(UK Office)
contact@elem.bio

Follow us on:

© 2026 ELEM Biotech SL. All rights reserved

Legal Notice
Privacy Policy
Cookies Policy